FEEDBACK
PLEASE WAIT ...
CLOSE
CLOSE

Manufacturer

Country

Document

No Title 0.23 MB
Registration Date 27 Sep 2016
Share

Genexol® PM

(0)

Medicine Pharmaceuticals

Antineoplastic Agent

Drug Information

Generic
Paclitaxel
Drug Class
Mitotic inhibitors
Therapeutic Class
Antineoplastic Agent
Dosage form
Suspension
Route of Administration
Intravenous Injection
Therapeutic Area
1.Various cancers

Indication

Breast Cancer 1) First-line treatment of metastatic or recurrent breast cancer. 2) Second-line treatment of metastatic breast cancer after failure of standard chemotherapy. Lung Cancer 1) First-line treatment of locally advanced or metastatic non-small cell lung cancer. Ovarian cancer 1) First-line treatment in combination with other chemotherapeutic agents.

Benefit

The new formulation is free from toxic surfactant and allows significantly higher dosing of paclitaxel to the patients. (The goal of polymeric micelle technology is to enhance solublization of water insoluble drugs to facilitate formulation of therapeutcally more effective products)